NCT02793934

Brief Summary

The Programme is focused on adult patients of any gender and age more than 18 y.o., with the next conditions:

  1. 1.Acute cerebrovascular events (ACE, ischemic stroke or intracerebral hemorrhage - specialty neurology)
  2. 2.Acute myocardial infarction (AMI, specialty cardiology)
  3. 3.Patients after total hip replacement (THR, specialty orthopaedia) The program is performed in the in-patient and out-patient rehabilitation departments in 13 regions of the Russian Federation (total 244 departments).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2015

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2015

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

May 15, 2016

Completed
24 days until next milestone

First Posted

Study publicly available on registry

June 8, 2016

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2020

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2020

Completed
Last Updated

April 26, 2018

Status Verified

April 1, 2018

Enrollment Period

5 years

First QC Date

May 15, 2016

Last Update Submit

April 24, 2018

Conditions

Keywords

RehabilitationICFPilot projectStrokeAcute myocardial infarctionTotal hip replacement

Outcome Measures

Primary Outcomes (2)

  • Mortality

    through study completion, an average of 1 month

  • Recovery of functions, activity and participation

    modified Renkin scale)

    through study completion, an average of 1 month

Secondary Outcomes (9)

  • Mortality

    90 days after discharge

  • Recovery of functions, activity and participation

    90 days after discharge

  • Environmental adaptation

    90 days after discharge

  • Preventable conditions

    90 days after discharge

  • Time of start of rehabilitation

    through study completion, an average of 1 month

  • +4 more secondary outcomes

Other Outcomes (4)

  • Criteria of rehabilitation potential

    up to 6 months

  • Criteria for the transferring to the next stage or to another hospital

    up to 6 months

  • Case mix groups on basic functional disturbances (by ICF)

    up to 6 months

  • +1 more other outcomes

Study Arms (2)

1st phase

In the 1st phase of the study the staff of the medical organizations continue to work in the familiar "old" scheme, but using the set of scales.

Other: ScalesOther: Old model of rehabilitationOther: ICF reader

2nd phase

In the 2nd phase, medical organizations will start to work on a new model with the implementation of problem-oriented multidisciplinary approach and the use of modern rehabilitation technologies. There is planning to use clearly defined criteria for transfer from stage to stage, developed by the professional community. When doctors will be trained program "ICF-reader" will have an opportunity to establish a rehabilitation diagnosis on the basis of the ICF, and the option for ICF assessment using rating scales.

Other: ScalesOther: New model of rehabilitationOther: ICF reader

Interventions

ScalesOTHER

For stroke patients there are used scales: Modified Rankin Scale, NIH Stroke Scale , Glasgow Coma Scale, Dysphagia Severity, Rating Scale Speech or Language Impairment Severity Rating Scale, Modified Rivermead Mobility Index, Berg Balance Scale, Modified Ashworth Scale, Medical Research Council Scale, Frenchay Arm Test, Montreal Cognitive Assessment Scale, Spielberger Scale, Beck's Depression Inventory, Visual Analogue Scale, Functional Independence Measure For patients after AMI: Rankin scale, GRACE scale, MoCA, VAS, Hospital scale of anxiety and depression, Canadian classification if stenocardia For patients after THR: The pain of the operated joint on VAS scores The Harris scale (the total amount), Scale Lequesne (total), Hospital scale of anxiety

1st phase2nd phase
1st phase2nd phase

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The Programme is focused on adult patients of any gender and age more than 18 y.o., with the next conditions: Acute cerebrovascular events (ACE, ischemic stroke or intracerebral hemorrhage - specialty neurology) Acute myocardial infarction (AMI, specialty cardiology) Patients after total hip replacement (THR, specialty orthopaedia)

You may qualify if:

  • Age over 18 years old
  • Ischemic stroke or intracerebral hemorrhage
  • Patients with acute myocardial infarction with elevation of segment ST (STMI)
  • Total hip replacement caused by degenerative processes

You may not qualify if:

  • uncorrected metabolic diseases (diabetes mellitus, myxoedema, thyrotoxicosis);
  • III hepatic or pancreatic insufficiency
  • heavy or repeated hemorrhages of any reason or anaemia Hb\<80g/l;
  • parasitoses;
  • acute infectious disease;
  • active stage of any form of tuberculosis;
  • patients with transmissible sexual diseases;
  • mental illness with personality desocialisation;
  • complicate ventricular rhythm disturbances
  • high risk of thromboembolism
  • absence of motivation
  • decompensation of somatic functions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

StPetersburgSPMU

Saint Petersburg, 197022, Russia

RECRUITING

Related Publications (7)

  • Winstein CJ, Stein J, Arena R, Bates B, Cherney LR, Cramer SC, Deruyter F, Eng JJ, Fisher B, Harvey RL, Lang CE, MacKay-Lyons M, Ottenbacher KJ, Pugh S, Reeves MJ, Richards LG, Stiers W, Zorowitz RD; American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Quality of Care and Outcomes Research. Guidelines for Adult Stroke Rehabilitation and Recovery: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2016 Jun;47(6):e98-e169. doi: 10.1161/STR.0000000000000098. Epub 2016 May 4.

  • Duncan PW, Zorowitz R, Bates B, Choi JY, Glasberg JJ, Graham GD, Katz RC, Lamberty K, Reker D. Management of Adult Stroke Rehabilitation Care: a clinical practice guideline. Stroke. 2005 Sep;36(9):e100-43. doi: 10.1161/01.STR.0000180861.54180.FF. No abstract available.

  • Miller EL, Murray L, Richards L, Zorowitz RD, Bakas T, Clark P, Billinger SA; American Heart Association Council on Cardiovascular Nursing and the Stroke Council. Comprehensive overview of nursing and interdisciplinary rehabilitation care of the stroke patient: a scientific statement from the American Heart Association. Stroke. 2010 Oct;41(10):2402-48. doi: 10.1161/STR.0b013e3181e7512b. Epub 2010 Sep 2. No abstract available.

  • Law M, Polatajko H, Pollock N, McColl MA, Carswell A, Baptiste S. Pilot testing of the Canadian Occupational Performance Measure: clinical and measurement issues. Can J Occup Ther. 1994 Oct;61(4):191-7. doi: 10.1177/000841749406100403.

  • Pollock N, Baptiste S, Law M, McColl MA, Opzoomer A, Polatajko H. Occupational performance measures: a review based on the guidelines for the client-centred practice of occupational therapy. Can J Occup Ther. 1990 Apr;57(2):77-81. doi: 10.1177/000841749005700206.

  • Kube E, Erhardt E. [Drug abuse prevention by police educational measures--Some remarks]. Arch Kriminol. 1991 Jan-Feb;187(2):23-7. No abstract available. German.

  • Robbins CE, Casey D, Bono JV, Murphy SB, Talmo CT, Ward DM. A multidisciplinary total hip arthroplasty protocol with accelerated postoperative rehabilitation: does the patient benefit? Am J Orthop (Belle Mead NJ). 2014 Apr;43(4):178-81.

Related Links

MeSH Terms

Conditions

Stroke

Interventions

Weights and Measures

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Investigative Techniques

Study Officials

  • Shmonin Alexey, PhD

    St. Petersburg State Pavlov Medical University

    PRINCIPAL INVESTIGATOR
  • Shamalov Nikolay, Professor

    Pirogov Russian National Medical Research University

    PRINCIPAL INVESTIGATOR
  • Suvorov Andrey, PhD

    Pirogov Russian National Medical Research University

    PRINCIPAL INVESTIGATOR
  • Buylova Tatiana, Professor

    Rehabilitation Center of Federal State Unitary Enterprise Nizhegorodskoye PROP

    PRINCIPAL INVESTIGATOR
  • Tsykunov Mikhail, Professor

    Central Research Institute of Traumatology and Orthopedics . Priorov Russian Ministry of Health

    PRINCIPAL INVESTIGATOR
  • Belyaev Anatoliy, Professor

    Vladivostok State Medical University

    PRINCIPAL INVESTIGATOR
  • Prokopenko Sergei, Professor

    Krasnoyarsk State Medical University named after Prof. V.F.Voino-Yasenetsky

    PRINCIPAL INVESTIGATOR
  • Khasanova Dina, Professor

    Kazan State Medical University Russian Ministry of Health

    PRINCIPAL INVESTIGATOR
  • Bodrova Rezeda, PhD

    Kazan State Medical Academy

    PRINCIPAL INVESTIGATOR
  • Aronov David, Professor

    State Research Center for Preventive Medicine Health Ministry of Russia

    PRINCIPAL INVESTIGATOR
  • Bubnova Marina, Professor

    State Research Center for Preventive Medicine Health Ministry of Russia

    PRINCIPAL INVESTIGATOR
  • Belkin Anatoliy, Professor

    Ural State Medical University Russian Ministry of Health

    PRINCIPAL INVESTIGATOR
  • Mishina Irina, Professor

    Ivanovo State Medical Academy Russian Ministry of Health

    PRINCIPAL INVESTIGATOR
  • Sarana Andrey, PhD

    Saint-Petersburg City Hospital â„– 40 of Recreation Area

    PRINCIPAL INVESTIGATOR
  • Ivanova Natalya, Professor

    Russian Research Neurosurgical Polenovs Institute

    PRINCIPAL INVESTIGATOR
  • Yashkov Alexander, Professor

    Samara State Medical University

    PRINCIPAL INVESTIGATOR
  • Maltseva Mariya, Professor

    St. Petersburg State Pavlov Medical University

    PRINCIPAL INVESTIGATOR
  • Soloveva Liudmila, MD

    St. Petersburg State Pavlov Medical University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ivanova Galina, Professor

CONTACT

Melnikova Elena, Professor

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 15, 2016

First Posted

June 8, 2016

Study Start

September 1, 2015

Primary Completion

September 1, 2020

Study Completion

December 1, 2020

Last Updated

April 26, 2018

Record last verified: 2018-04

Data Sharing

IPD Sharing
Will not share

Locations